Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Better Buy: Biogen vs. Gilead Sciences

TheMotleyFool

0 0

Better Buy: Biogen vs. Gilead SciencesPhoto, wide shot, wide-angle lens, Clinical research organization, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by David Maisel: https://img.theapi.app/temp/0e9d087d-988e-4397-b7cf-6049e2776769.png

Biogen (NASDAQ: BIIB) and Gilead Sciences (NASDAQ: GILD) are both biotech royalty. In the not-so-distant past, these two top biotech stocks clobbered the broader markets in terms of their share price performance, and they did so for several years running.

However, Biogen and Gilead have both hit a rough patch over the past few years, causing their shares to lag behind the high-flying biotech industry. Which of these elite biotech companies is in the best position to get back to their winning ways? Let's take a look at how Biogen and Gilead stack up in several key areas to find out.

Image Source: Getty Images.

Source Fool.com

Like: 0

GILD

Share